CLINILABS ATTENDS 48TH ANNUAL NCDEU MEETING
– Clinilabs, Inc., a specialty contract research organization (CRO), will be attending the 48th Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting, scheduled to take place at the Arizona Biltmore Hotel in Phoenix, Arizona. The Meeting will be held from May 27 through the 30th, bringing together over 1,000 scientific professionals from multiple healthcare disciplines involved in clinical research.
The NCDEU Meeting is co-sponsored by the National Institute of Mental Health (NIMH) and the American Society of Clinical Psychopharmacology (ASCP). The Meeting aims to address the latest developments in psychopharmacologic clinical research and related methodology. “The Annual NCDEU Meeting presents a great opportunity for industry professionals to learn and understand the new developments in psychiatric treatment and examine recent advances in the field of psychopharmacology,” stated Dr. Gary Zammit, President & CEO of Clinilabs.
At this year’s Meeting, Clinilabs will be hosting a private baseball outing on May 28th at Chase Field, where the Arizona Diamondbacks will be facing the San Francisco Giants. Clinilabs’ has reserved the Stadium’s Riviera Pools Pavilion, Major League Baseball’s only swimming pool and spa entertainment center, for this event. Invited attendees will be able to enjoy food and cocktails while watching the game live from the poolside.
If you are interested in attending this event, there may still be some tickets available. Please contact Jeanine Estrada at 212-981-2716 or via e-mail at jestrada@clinilabs.com to reserve your space for the game.
Clinilabs is a specialty contract research organization (CRO) that provides a full portfolio of services to pharmaceutical, biotechnology, and medical device companies involved in the development of central nervous system (CNS) and cardiovascular (CV) therapeutics. The Company also provides early phase services in a wider range of therapeutic areas at its Phase I facility. Established in 2001, Clinilabs has provided services to more than one third of the world’s top 20 pharmaceutical companies, and has been involved in more than 10 successful New Drug Applications (NDAs) in central nervous system (CNS) and cardiovascular (CV) indications.
For more information about Clinilabs and or to schedule an appointment with one of our representatives, please contact Jeanine Estrada at 212-981-2716 or via e-mail at jestrada@clinilabs.com.
For more information on the NCDEU Annual Meeting or to register for the event, please call 703-925-9455 or e-mail icg@infinityconferences.com. |
